PT2277546E - Formulação de paracetamol injectável estável pronta a utilizar - Google Patents

Formulação de paracetamol injectável estável pronta a utilizar Download PDF

Info

Publication number
PT2277546E
PT2277546E PT90095696T PT09009569T PT2277546E PT 2277546 E PT2277546 E PT 2277546E PT 90095696 T PT90095696 T PT 90095696T PT 09009569 T PT09009569 T PT 09009569T PT 2277546 E PT2277546 E PT 2277546E
Authority
PT
Portugal
Prior art keywords
use injectable
stable ready
paracetamol formulation
injectable paracetamol
formulation
Prior art date
Application number
PT90095696T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab S A, Ioulia Tseti filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Publication of PT2277546E publication Critical patent/PT2277546E/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT90095696T 2009-07-23 2009-07-23 Formulação de paracetamol injectável estável pronta a utilizar PT2277546E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09009569.6A EP2277546B1 (en) 2009-07-23 2009-07-23 Stable ready to use injectable paracetamol formulation

Publications (1)

Publication Number Publication Date
PT2277546E true PT2277546E (pt) 2015-09-25

Family

ID=41264251

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90095696T PT2277546E (pt) 2009-07-23 2009-07-23 Formulação de paracetamol injectável estável pronta a utilizar

Country Status (11)

Country Link
EP (1) EP2277546B1 (pt)
CY (1) CY1116746T1 (pt)
DK (1) DK2277546T3 (pt)
ES (1) ES2545484T3 (pt)
HK (1) HK1153400A1 (pt)
HR (1) HRP20150815T1 (pt)
HU (1) HUE027032T2 (pt)
PL (1) PL2277546T3 (pt)
PT (1) PT2277546E (pt)
SI (1) SI2277546T1 (pt)
SM (1) SMT201500192B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
CN110167543A (zh) * 2016-09-16 2019-08-23 锡德克斯药物公司 包含对乙酰氨基酚和磺烷基醚环糊精的制剂
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
WO2003051398A1 (en) * 2001-12-18 2003-06-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteral composition of paracetamol
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
CA2661193A1 (en) * 2006-08-08 2008-02-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic methods for neuropathic pain
JP5909750B2 (ja) * 2007-11-13 2016-04-27 マリンクロット アイピー 低用量静脈内アセトアミノフェン

Also Published As

Publication number Publication date
CY1116746T1 (el) 2017-03-15
SMT201500192B (it) 2015-09-07
HRP20150815T1 (hr) 2015-09-11
PL2277546T3 (pl) 2015-10-30
SI2277546T1 (sl) 2015-09-30
HUE027032T2 (en) 2016-08-29
EP2277546B1 (en) 2015-07-15
DK2277546T3 (en) 2015-08-17
EP2277546A1 (en) 2011-01-26
ES2545484T3 (es) 2015-09-11
HK1153400A1 (en) 2012-03-30

Similar Documents

Publication Publication Date Title
EP2616064A4 (en) KETOROLAC FORMULATIONS READY TO USE
DK2387989T3 (da) Langtidsvirkende formuleringer med insuliner
EP2646468A4 (en) ANTI-NGF COMPOSITIONS AND THEIR USE
GB201010193D0 (en) Medicinal use
IL225238A0 (en) pharmaceutical preparation
IL225457A0 (en) Pharmaceutical composition
LT2619182T (lt) Farmacinė kompozicija
ZA201208726B (en) High-temperature stable oxygen-carrier-containing pharmaceutical composition
IL221857A (en) Liquid formulations are stabilized
HK1182315A1 (en) Stable ready to use injectable paracetamol formulation
EP2599484A4 (en) INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE
IL239049A0 (en) Dimeric compounds containing oxazolidinone, preparations, methods for their preparation and their use
AU332760S (en) Spatula head
GB201010453D0 (en) Pharmaceutical composition
IL215265A0 (en) Syringe for single use
HK1153400A1 (en) Stable ready to use injectable paracetamol formulation
IL206739A0 (en) Injectable pharmaceutical composition
GB201001911D0 (en) Pharmaceutical composition
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
ZA201300098B (en) Pharmaceutical composition with enhanced solubility characteristics
GB201010242D0 (en) Single use disposable feet protectors with advertising purpose for external use
ZA200808734B (en) Injectable liquid paracetamol formulation
IL208677A0 (en) Spatula
HU1000006D0 (en) Improved pharmaceutical composition
PL393180A1 (pl) Preparat weterynaryjny